Positron Corporation, a medical technology company, co-develops, manufactures, and sells positron emission tomography and PET-computed tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, billing and prior-authorization assistance, physician over-read services, 24/7 clinical and technical support, priority response with after-hours service availability, equipment uptime guarantees and software upgrades, and remote system diagnostics and maintenance capabilities. The company sells its products through internal sales and marketing team. It serves healthcare providers, imaging centers, hospitals, and cardiology practices. The company was incorporated in 1983 and is headquartered in North Tonawanda, New York.
Frequently asked questions
What sector does Positron Corp (POSC) operate in?
Positron Corp belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Positron Corp (POSC) current stock price?
As of the latest data, Positron Corp stock price is $1.72, with a previous close of $1.70. Positron Corp gained $0.02 in the last trading session, representing a 1.18% increase.
What is Positron Corp (POSC) current market capitalization?
Positron Corp market cap is approximately 56.49 million.
What is Positron Corp (POSC) Earnings Per Share (EPS)?
The trailing EPS is -$0.29.
What is Positron Corp (POSC) EBITDA?
Positron Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -784.51 thousand.
Does Positron Corp (POSC) pay dividends?
No. Positron Corp does not pay a dividend.
What is Positron Corp (POSC) beta (volatility) score?
Positron Corp has a beta of 0.533, indicating lower volatility than the overall market.
